메뉴 건너뛰기




Volumn 9, Issue 7, 2014, Pages

Efficacy of selective PDE4D negative allosteric modulators in the object retrieval task in female cynomolgus monkeys (Macaca fascicularis)

Author keywords

[No Author keywords available]

Indexed keywords

D 159687; D 159797; PHOSPHODIESTERASE IV INHIBITOR; ROLIPRAM; UNCLASSIFIED DRUG; BENZHYDRYL DERIVATIVE; CARBANILAMIDE DERIVATIVE; D159687; NOOTROPIC AGENT; PHOSPHODIESTERASE IV;

EID: 84904632632     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102449     Document Type: Article
Times cited : (25)

References (72)
  • 2
    • 4444262374 scopus 로고    scopus 로고
    • The type IV-specific phosphodiesterase inhibitor rolipram and its effect on hippocampal long-term potentiation and synaptic tagging
    • DOI 10.1523/JNEUROSCI.1796-04.2004
    • Navakkode S, Sajikumar S, Frey JU (2004) The type IV-specific phosphodiesterase inhibitor rolipram and its effect on hippocampal long-term potentiation and synaptic tagging. J Neurosci 24: 7740-7744. (Pubitemid 39186829)
    • (2004) Journal of Neuroscience , vol.24 , Issue.35 , pp. 7740-7744
    • Navakkode, S.1    Sajikumar, S.2    Frey, J.U.3
  • 3
    • 54849409586 scopus 로고    scopus 로고
    • Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum
    • Nishi A, Kuroiwa M, Miller DB, O'Callaghan JP, Bateup HS, et al. (2008) Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum. J Neurosci 28: 10460-10471.
    • (2008) J Neurosci , vol.28 , pp. 10460-10471
    • Nishi, A.1    Kuroiwa, M.2    Miller, D.B.3    O'Callaghan, J.P.4    Bateup, H.S.5
  • 5
    • 84885174946 scopus 로고    scopus 로고
    • The role of phosphodiesterases in hippocampal synaptic plasticity
    • Sanderson TM, Sher E (2013) The role of phosphodiesterases in hippocampal synaptic plasticity. Neuropharmacology 74: 86-95.
    • (2013) Neuropharmacology , vol.74 , pp. 86-95
    • Sanderson, T.M.1    Sher, E.2
  • 6
    • 77955374442 scopus 로고    scopus 로고
    • The role of type 4 phosphodiesterases in generating microdomains of cAMP: Large scale stochastic simulations
    • Oliveira RF, Terrin A, Di Benedetto G, Cannon RC, Koh W, et al. (2010) The role of type 4 phosphodiesterases in generating microdomains of cAMP: large scale stochastic simulations. PLoS One 5: e11725.
    • (2010) PLoS One , vol.5
    • Oliveira, R.F.1    Terrin, A.2    Di Benedetto, G.3    Cannon, R.C.4    Koh, W.5
  • 7
    • 0027203084 scopus 로고
    • Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons
    • Frey U, Huang YY, Kandel ER (1993) Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons. Science 260: 1661-1664. (Pubitemid 23247151)
    • (1993) Science , vol.260 , Issue.5114 , pp. 1661-1664
    • Frey, U.1    Huang, Y.-Y.2    Kandel, E.R.3
  • 8
    • 33846975147 scopus 로고    scopus 로고
    • Role of phosphodiesterases in neurological and psychiatric disease
    • DOI 10.1016/j.coph.2006.08.014, PII S1471489206001950, Neurosciences
    • Hebb AL, Robertson HA (2007) Role of phosphodiesterases in neurological and psychiatric disease. Curr Opin Pharmacol 7: 86-92. (Pubitemid 46242039)
    • (2007) Current Opinion in Pharmacology , vol.7 , Issue.1 , pp. 86-92
    • Hebb, A.L.1    Robertson, H.A.2
  • 9
    • 24944520099 scopus 로고    scopus 로고
    • Phosphodiesterase inhibitors for cognitive enhancement
    • DOI 10.2174/138161205774370799
    • Rose GM, Hopper A, De Vivo M, Tehim A (2005) Phosphodiesterase inhibitors for cognitive enhancement. Curr Pharm Des 11: 3329-3334. (Pubitemid 41300762)
    • (2005) Current Pharmaceutical Design , vol.11 , Issue.26 , pp. 3329-3334
    • Rose, G.M.1    Hopper, A.2    De Vivo, M.3    Tehim, A.4
  • 10
    • 84885472234 scopus 로고    scopus 로고
    • Phosphodiesterases: Regulators of cyclic nucleotide signals and novel molecular target for movement disorders
    • Sharma S, Kumar K, Deshmukh R, Sharma PL (2013) Phosphodiesterases: Regulators of cyclic nucleotide signals and novel molecular target for movement disorders. Eur J Pharmacol 714: 486-497.
    • (2013) Eur J Pharmacol , vol.714 , pp. 486-497
    • Sharma, S.1    Kumar, K.2    Deshmukh, R.3    Sharma, P.L.4
  • 12
    • 78650891913 scopus 로고    scopus 로고
    • Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling
    • Li YF, Cheng YF, Huang Y, Conti M, Wilson SP, et al. (2011) Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling. J Neurosci 31: 172-183.
    • (2011) J Neurosci , vol.31 , pp. 172-183
    • Li, Y.F.1    Cheng, Y.F.2    Huang, Y.3    Conti, M.4    Wilson, S.P.5
  • 13
    • 70349150027 scopus 로고    scopus 로고
    • Antidepressant- and anxiolytic-like effects of the phosphodiesterase-4 inhibitor rolipram on behavior depend on cyclic AMP response element binding protein-mediated neurogenesis in the hippocampus
    • Li YF, Huang Y, Amsdell SL, Xiao L, O'Donnell JM, et al. (2009) Antidepressant- and anxiolytic-like effects of the phosphodiesterase-4 inhibitor rolipram on behavior depend on cyclic AMP response element binding protein-mediated neurogenesis in the hippocampus. Neuropsychopharmacology 34: 2404-2419.
    • (2009) Neuropsychopharmacology , vol.34 , pp. 2404-2419
    • Li, Y.F.1    Huang, Y.2    Amsdell, S.L.3    Xiao, L.4    O'Donnell, J.M.5
  • 14
    • 85047694516 scopus 로고    scopus 로고
    • Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment
    • DOI 10.1172/JCI200422831
    • Gong B, Vitolo OV, Trinchese F, Liu S, Shelanski M, et al. (2004) Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J Clin Invest 114: 1624-1634. (Pubitemid 40385553)
    • (2004) Journal of Clinical Investigation , vol.114 , Issue.11 , pp. 1624-1634
    • Gong, B.1    Vitolo, O.V.2    Trinchese, F.3    Liu, S.4    Shelanski, M.5    Arancio, O.6
  • 15
    • 84902124631 scopus 로고    scopus 로고
    • Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D
    • Sierksma AS, van den Hove DL, Pfau F, Philippens M, Bruno O, et al. (2013) Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D. Neuropharmacology.
    • (2013) Neuropharmacology
    • Sierksma, A.S.1    Van Den Hove, D.L.2    Pfau, F.3    Philippens, M.4    Bruno, O.5
  • 16
    • 79551554590 scopus 로고    scopus 로고
    • The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease
    • Munoz-Sanjuan I, Bates GP (2011) The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease. J Clin Invest 121: 476-483.
    • (2011) J Clin Invest , vol.121 , pp. 476-483
    • Munoz-Sanjuan, I.1    Bates, G.P.2
  • 17
    • 73749085726 scopus 로고    scopus 로고
    • Altered white matter microstructure in the corpus callosum in Huntington's disease: Implications for cortical "disconnection"
    • Rosas HD, Lee SY, Bender AC, Zaleta AK, Vangel M, et al. (2010) Altered white matter microstructure in the corpus callosum in Huntington's disease: implications for cortical "disconnection". Neuroimage 49: 2995-3004.
    • (2010) Neuroimage , vol.49 , pp. 2995-3004
    • Rosas, H.D.1    Lee, S.Y.2    Bender, A.C.3    Zaleta, A.K.4    Vangel, M.5
  • 18
    • 79961208186 scopus 로고    scopus 로고
    • A tale of two factors: What determines the rate of progression in Huntington's disease? A longitudinal MRI study
    • Rosas HD, Reuter M, Doros G, Lee SY, Triggs T, et al. (2011) A tale of two factors: what determines the rate of progression in Huntington's disease? A longitudinal MRI study. Mov Disord 26: 1691-1697.
    • (2011) Mov Disord , vol.26 , pp. 1691-1697
    • Rosas, H.D.1    Reuter, M.2    Doros, G.3    Lee, S.Y.4    Triggs, T.5
  • 19
    • 83555173501 scopus 로고    scopus 로고
    • Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: Analysis of 24 month observational data
    • Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, et al. (2012) Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data. Lancet Neurol 11: 42-53.
    • (2012) Lancet Neurol , vol.11 , pp. 42-53
    • Tabrizi, S.J.1    Reilmann, R.2    Roos, R.A.3    Durr, A.4    Leavitt, B.5
  • 20
    • 84876133677 scopus 로고    scopus 로고
    • Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy
    • Scahill RI, Hobbs NZ, Say MJ, Bechtel N, Henley SM, et al. (2011) Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy. Hum Brain Mapp.
    • (2011) Hum Brain Mapp
    • Scahill, R.I.1    Hobbs, N.Z.2    Say, M.J.3    Bechtel, N.4    Henley, S.M.5
  • 21
    • 17144386565 scopus 로고    scopus 로고
    • cAMP-response element-binding protein contributes to suppression of the A2A adenosine receptor promoter by mutant Huntingtin with expanded polyglutamine residues
    • Chiang MC, Lee YC, Huang CL, Chern Y (2005) cAMP-response element-binding protein contributes to suppression of the A2A adenosine receptor promoter by mutant Huntingtin with expanded polyglutamine residues. J Biol Chem 280: 14331-14340.
    • (2005) J Biol Chem , vol.280 , pp. 14331-14340
    • Chiang, M.C.1    Lee, Y.C.2    Huang, C.L.3    Chern, Y.4
  • 22
    • 43649092175 scopus 로고    scopus 로고
    • Beneficial effects of rolipram in the R6/2 mouse model of Huntington's disease
    • DeMarch Z, Giampa C, Patassini S, Bernardi G, Fusco FR (2008) Beneficial effects of rolipram in the R6/2 mouse model of Huntington's disease. Neurobiol Dis 30: 375-387.
    • (2008) Neurobiol Dis , vol.30 , pp. 375-387
    • DeMarch, Z.1    Giampa, C.2    Patassini, S.3    Bernardi, G.4    Fusco, F.R.5
  • 23
    • 33846386124 scopus 로고    scopus 로고
    • Beneficial effects of rolipram in a quinolinic acid model of striatal excitotoxicity
    • DOI 10.1016/j.nbd.2006.09.006, PII S0969996106002361
    • DeMarch Z, Giampa C, Patassini S, Martorana A, Bernardi G, et al. (2007) Beneficial effects of rolipram in a quinolinic acid model of striatal excitotoxicity. Neurobiol Dis 25: 266-273. (Pubitemid 46127843)
    • (2007) Neurobiology of Disease , vol.25 , Issue.2 , pp. 266-273
    • DeMarch, Z.1    Giampa, C.2    Patassini, S.3    Martorana, A.4    Bernardi, G.5    Fusco, F.R.6
  • 24
    • 61449226493 scopus 로고    scopus 로고
    • Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington's disease
    • Giampa C, Middei S, Patassini S, Borreca A, Marullo F, et al. (2009) Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington's disease. Eur J Neurosci 29: 902-910.
    • (2009) Eur J Neurosci , vol.29 , pp. 902-910
    • Giampa, C.1    Middei, S.2    Patassini, S.3    Borreca, A.4    Marullo, F.5
  • 25
    • 67349165136 scopus 로고    scopus 로고
    • Phosphodiesterase 10 inhibition reduces striatal excitotoxicity in the quinolinic acid model of Huntington's disease
    • Giampa C, Patassini S, Borreca A, Laurenti D, Marullo F, et al. (2009) Phosphodiesterase 10 inhibition reduces striatal excitotoxicity in the quinolinic acid model of Huntington's disease. Neurobiol Dis 34: 450-456.
    • (2009) Neurobiol Dis , vol.34 , pp. 450-456
    • Giampa, C.1    Patassini, S.2    Borreca, A.3    Laurenti, D.4    Marullo, F.5
  • 26
    • 0037335074 scopus 로고    scopus 로고
    • Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice
    • Gines S (2003) Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice. Human Molecular Genetics 12: 497-508.
    • (2003) Human Molecular Genetics , vol.12 , pp. 497-508
    • Gines, S.1
  • 27
    • 78650779872 scopus 로고    scopus 로고
    • Chronic suppression of phosphodiesterase 10A alters striatal expression of genes responsible for neurotransmitter synthesis, neurotransmission, and signaling pathways implicated in Huntington's disease
    • Kleiman RJ, Kimmel LH, Bove SE, Lanz TA, Harms JF, et al. (2011) Chronic suppression of phosphodiesterase 10A alters striatal expression of genes responsible for neurotransmitter synthesis, neurotransmission, and signaling pathways implicated in Huntington's disease. J Pharmacol Exp Ther 336: 64-76.
    • (2011) J Pharmacol Exp Ther , vol.336 , pp. 64-76
    • Kleiman, R.J.1    Kimmel, L.H.2    Bove, S.E.3    Lanz, T.A.4    Harms, J.F.5
  • 28
    • 0742287915 scopus 로고    scopus 로고
    • CRE-Mediated Transcription Is Increased in Huntington's Disease Transgenic Mice
    • DOI 10.1523/JNEUROSCI.3493-03.2004
    • Obrietan K, Hoyt KR (2004) CRE-mediated transcription is increased in Huntington's disease transgenic mice. J Neurosci 24: 791-796. (Pubitemid 38146589)
    • (2004) Journal of Neuroscience , vol.24 , Issue.4 , pp. 791-796
    • Obrietan, K.1    Hoyt, K.R.2
  • 29
    • 77951206413 scopus 로고    scopus 로고
    • Sildenafil protects against 3-nitropropionic acid neurotoxicity through the modulation of calpain, CREB, and BDNF
    • Puerta E, Hervias I, Barros-Minones L, Jordan J, Ricobaraza A, et al. (2010) Sildenafil protects against 3-nitropropionic acid neurotoxicity through the modulation of calpain, CREB, and BDNF. Neurobiol Dis 38: 237-245.
    • (2010) Neurobiol Dis , vol.38 , pp. 237-245
    • Puerta, E.1    Hervias, I.2    Barros-Minones, L.3    Jordan, J.4    Ricobaraza, A.5
  • 30
    • 1042289730 scopus 로고    scopus 로고
    • Decreased cAMP response element-mediated transcription. An early event in exon 1 and full-length cell models of Huntington's disease that contributes to polyglutamine pathogenesis
    • DOI 10.1074/jbc.M310226200
    • Sugars KL, Brown R, Cook LJ, Swartz J, Rubinsztein DC (2004) Decreased cAMP response element-mediated transcription: an early event in exon 1 and full-length cell models of Huntington's disease that contributes to polyglutamine pathogenesis. J Biol Chem 279: 4988-4999. (Pubitemid 38199095)
    • (2004) Journal of Biological Chemistry , vol.279 , Issue.6 , pp. 4988-4999
    • Sugars, K.L.1    Brown, R.2    Cook, L.J.3    Swartz, J.4    Rubinsztein, D.C.5
  • 31
    • 34147136044 scopus 로고    scopus 로고
    • CREB-binding protein modulates repeat instability in a Drosophila model for polyQ disease
    • DOI 10.1126/science.1139517
    • Jung J, Bonini N (2007) CREB-binding protein modulates repeat instability in a Drosophila model for polyQ disease. Science 315: 1857-1859. (Pubitemid 46580147)
    • (2007) Science , vol.315 , Issue.5820 , pp. 1857-1859
    • Jung, J.1    Bonini, N.2
  • 34
    • 0027314157 scopus 로고
    • Effects of repeated administration of rolipram, a cAMP-specific phosphodiesterase inhibitor, on acetylcholinergic indices in the aged rat brain
    • DOI 10.1016/0167-4943(93)90009-7
    • Asanuma M, Ogawa N, Kondo Y, Hirata H, Mori A (1993) Effects of repeated administration of rolipram, a cAMP-specific phosphodiesterase inhibitor, on acetylcholinergic indices in the aged rat brain. Arch Gerontol Geriatr 16: 191-198. (Pubitemid 23196747)
    • (1993) Archives of Gerontology and Geriatrics , vol.16 , Issue.2 , pp. 191-198
    • Asanuma, M.1    Ogawa, N.2    Kondo, Y.3    Hirata, H.4    Mori, A.5
  • 35
    • 48149108931 scopus 로고    scopus 로고
    • Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs
    • Bateup HS, Svenningsson P, Kuroiwa M, Gong S, Nishi A, et al. (2008) Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs. Nat Neurosci 11: 932-939.
    • (2008) Nat Neurosci , vol.11 , pp. 932-939
    • Bateup, H.S.1    Svenningsson, P.2    Kuroiwa, M.3    Gong, S.4    Nishi, A.5
  • 36
    • 74049158987 scopus 로고    scopus 로고
    • Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety
    • Burgin AB, Magnusson OT, Singh J, Witte P, Staker BL, et al. (2010) Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety. Nat Biotechnol 28: 63-70.
    • (2010) Nat Biotechnol , vol.28 , pp. 63-70
    • Burgin, A.B.1    Magnusson, O.T.2    Singh, J.3    Witte, P.4    Staker, B.L.5
  • 37
    • 27344449614 scopus 로고    scopus 로고
    • Keynote review: Phosphodiesterase-4 as a therapeutic target
    • DOI 10.1016/S1359-6446(05)03622-6, PII S1359644605036226
    • Houslay MD, Schafer P, Zhang KYJ (2005) Keynote review: Phosphodiesterase-4 as a therapeutic target. Drug Discovery Today 10: 1503-1519. (Pubitemid 41527193)
    • (2005) Drug Discovery Today , vol.10 , Issue.22 , pp. 1503-1519
    • Houslay, M.D.1    Schafer, P.2    Zhang, K.Y.J.3
  • 39
    • 84873095711 scopus 로고    scopus 로고
    • Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex
    • Kuroiwa M, Snyder GL, Shuto T, Fukuda A, Yanagawa Y, et al. (2011) Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex. Psychopharmacology (Berl).
    • (2011) Psychopharmacology (Berl)
    • Kuroiwa, M.1    Snyder, G.L.2    Shuto, T.3    Fukuda, A.4    Yanagawa, Y.5
  • 40
    • 84904696602 scopus 로고    scopus 로고
    • Selective phosphodiesterase inhibitors improve performance on the ED/ID cognitive task in rats
    • Rodefer JS, Saland SK, Eckrich SJ (2011) Selective phosphodiesterase inhibitors improve performance on the ED/ID cognitive task in rats. Neuropharmacology.
    • (2011) Neuropharmacology
    • Rodefer, J.S.1    Saland, S.K.2    Eckrich, S.J.3
  • 41
    • 43049118254 scopus 로고    scopus 로고
    • Selective PDE inhibitors rolipram and sildenafil improve object retrieval performance in adult cynomolgus macaques
    • Rutten K, Basile JL, Prickaerts J, Blokland A, Vivian JA (2008) Selective PDE inhibitors rolipram and sildenafil improve object retrieval performance in adult cynomolgus macaques. Psychopharmacology (Berl) 196: 643-648.
    • (2008) Psychopharmacology (Berl) , vol.196 , pp. 643-648
    • Rutten, K.1    Basile, J.L.2    Prickaerts, J.3    Blokland, A.4    Vivian, J.A.5
  • 42
    • 57049135076 scopus 로고    scopus 로고
    • In vivo effects of phosphodiesterase inhibition on basal cyclic guanosine monophosphate levels in the prefrontal cortex, hippocampus and cerebellum of freely moving rats
    • Marte A, Pepicelli O, Cavallero A, Raiteri M, Fedele E (2008) In vivo effects of phosphodiesterase inhibition on basal cyclic guanosine monophosphate levels in the prefrontal cortex, hippocampus and cerebellum of freely moving rats. J Neurosci Res 86: 3338-3347.
    • (2008) J Neurosci Res , vol.86 , pp. 3338-3347
    • Marte, A.1    Pepicelli, O.2    Cavallero, A.3    Raiteri, M.4    Fedele, E.5
  • 44
    • 62449195496 scopus 로고    scopus 로고
    • Inhibition of Phosphodiesterase 10A Increases the Responsiveness of Striatal Projection Neurons to Cortical Stimulation
    • Threlfell S, Sammut S, Menniti FS, Schmidt CJ, West AR (2009) Inhibition of Phosphodiesterase 10A Increases the Responsiveness of Striatal Projection Neurons to Cortical Stimulation. J Pharmacol Exp Ther 328: 785-795.
    • (2009) J Pharmacol Exp Ther , vol.328 , pp. 785-795
    • Threlfell, S.1    Sammut, S.2    Menniti, F.S.3    Schmidt, C.J.4    West, A.R.5
  • 45
    • 34247596903 scopus 로고    scopus 로고
    • The PDE4 inhibitor rolipram reverses object memory impairment induced by acute tryptophan depletion in the rat
    • DOI 10.1007/s00213-006-0697-4
    • Rutten K, Lieben C, Smits L, Blokland A (2007) The PDE4 inhibitor rolipram reverses object memory impairment induced by acute tryptophan depletion in the rat. Psychopharmacology (Berl) 192: 275-282. (Pubitemid 46669202)
    • (2007) Psychopharmacology , vol.192 , Issue.2 , pp. 275-282
    • Rutten, K.1    Lieben, C.2    Smits, L.3    Blokland, A.4
  • 46
    • 32644461812 scopus 로고    scopus 로고
    • Rolipram reverses scopolamine-induced and time-dependent memory deficits in object recognition by different mechanisms of action
    • DOI 10.1016/j.nlm.2005.09.002, PII S1074742705000869
    • Rutten K, Prickaerts J, Blokland A (2006) Rolipram reverses scopolamine-induced and time-dependent memory deficits in object recognition by different mechanisms of action. Neurobiol Learn Mem 85: 132-138. (Pubitemid 43247839)
    • (2006) Neurobiology of Learning and Memory , vol.85 , Issue.2 , pp. 132-138
    • Rutten, K.1    Prickaerts, J.2    Blokland, A.3
  • 47
    • 0031048406 scopus 로고    scopus 로고
    • Ameliorating effects of rolipram on experimentally induced impairments of learning and memory in rodents
    • DOI 10.1016/S0014-2999(96)00969-7, PII S0014299996009697
    • Imanishi T, Sawa A, Ichimaru Y, Miyashiro M, Kato S, et al. (1997) Ameliorating effects of rolipram on experimentally induced impairments of learning and memory in rodents. Eur J Pharmacol 321: 273-278. (Pubitemid 27105928)
    • (1997) European Journal of Pharmacology , vol.321 , Issue.3 , pp. 273-278
    • Imanishi, T.1    Sawa, A.2    Ichimaru, Y.3    Miyashiro, M.4    Kato, S.5    Yamamoto, T.6    Ueki, S.7
  • 48
    • 0024045691 scopus 로고
    • Rolipram versus imipramine in inpatients with major, "minor" or atypical depressive disorder: A double-blind double-dummy study aimed at testing a novel therapeutic approach
    • Bertolino A, Crippa D, di Dio S, Fichte K, Musmeci G, et al. (1988) Rolipram versus imipramine in inpatients with major, "minor" or atypical depressive disorder: a double-blind double-dummy study aimed at testing a novel therapeutic approach. Int Clin Psychopharmacol 3: 245-253.
    • (1988) Int Clin Psychopharmacol , vol.3 , pp. 245-253
    • Bertolino, A.1    Crippa, D.2    Di Dio, S.3    Fichte, K.4    Musmeci, G.5
  • 50
    • 36749000152 scopus 로고    scopus 로고
    • Structures of the four subfamilies of phosphodiesterases provide insight into the selectivity of their inhibitors
    • DOI 10.1042/BJ20070970
    • Wang H, Peng MS, Chen Y, Geng J, Robinson H, et al. (2007) Structures of the four subfamilies of phosphodiesterase-4 provide insight into the selectivity of their inhibitors. Biochem J 408: 193-201. (Pubitemid 350206342)
    • (2007) Biochemical Journal , vol.408 , Issue.2 , pp. 193-201
    • Wang, H.1    Peng, M.-S.2    Chen, Y.3    Geng, J.4    Robinson, H.5    Houslay, M.D.6    Cai, J.7    Ke, H.8
  • 51
    • 81455151817 scopus 로고    scopus 로고
    • GEBR-7b, a novel PDE4D selective inhibitor that improves memory in rodents at non-emetic doses
    • Bruno O, Fedele E, Prickaerts J, Parker LA, Canepa E, et al. (2011) GEBR-7b, a novel PDE4D selective inhibitor that improves memory in rodents at non-emetic doses. Br J Pharmacol 164: 2054-2063.
    • (2011) Br J Pharmacol , vol.164 , pp. 2054-2063
    • Bruno, O.1    Fedele, E.2    Prickaerts, J.3    Parker, L.A.4    Canepa, E.5
  • 52
    • 79955803729 scopus 로고    scopus 로고
    • ASP3258, an orally active potent phosphodiesterase 4 inhibitor with low emetic activity
    • Kobayashi M, Kubo S, Iwata M, Ohtsu Y, Takahashi K, et al. (2011) ASP3258, an orally active potent phosphodiesterase 4 inhibitor with low emetic activity. Int Immunopharmacol 11: 732-739.
    • (2011) Int Immunopharmacol , vol.11 , pp. 732-739
    • Kobayashi, M.1    Kubo, S.2    Iwata, M.3    Ohtsu, Y.4    Takahashi, K.5
  • 54
    • 0033043309 scopus 로고    scopus 로고
    • Emesis induced by inhibitors of type IV cyclic nucleotide phosphodiesterase (PDE IV) in the ferret
    • DOI 10.1016/S0028-3908(98)00190-7, PII S0028390898001907
    • Robichaud A, Tattersall FD, Choudhury I, Rodger IW (1999) Emesis induced by inhibitors of type IV cyclic nucleotide phosphodiesterase (PDE IV) in the ferret. Neuropharmacology 38: 289-297. (Pubitemid 29073550)
    • (1999) Neuropharmacology , vol.38 , Issue.2 , pp. 289-297
    • Robichaud, A.1    Tattersall, F.D.2    Choudhury, I.3    Rodger, I.W.4
  • 55
    • 0024380592 scopus 로고
    • Successful performance by monkeys with lesions of the hippocampal formation on AB and object retrieval, two tasks that mark developmental changes in human infants
    • DOI 10.1037/0735-7044.103.3.526
    • Diamond A, Zola-Morgan S, Squire LR (1989) Successful performance by monkeys with lesions of the hippocampal formation on AB and object retrieval, two tasks that mark developmental changes in human infants. Behav Neurosci 103: 526-537. (Pubitemid 19161166)
    • (1989) Behavioral Neuroscience , vol.103 , Issue.3 , pp. 526-537
    • Diamond, A.1    Zola-Morgan, S.2    Squire, L.R.3
  • 57
    • 0029858598 scopus 로고    scopus 로고
    • Primate analogue of the Wisconsin Card Sorting Test: Effects of excitotoxic lesions of the prefrontal cortex in the marmoset
    • DOI 10.1037/0735-7044.110.5.872
    • Dias R, Robbins TW, Roberts AC (1996) Primate analogue of the Wisconsin Card Sorting Test: effects of excitotoxic lesions of the prefrontal cortex in the marmoset. Behav Neurosci 110: 872-886. (Pubitemid 26365787)
    • (1996) Behavioral Neuroscience , vol.110 , Issue.5 , pp. 872-886
    • Dias, R.1    Robbins, T.W.2    Roberts, A.C.3
  • 58
    • 0034114762 scopus 로고    scopus 로고
    • Inhibitory control and affective processing in the prefrontal cortex: Neuropsychological studies in the common marmoset
    • Roberts AC, Wallis JD (2000) Inhibitory Control and Affective Processing in the Prefrontal Cortex: Neuropsychological Studies in the Common Marmoset. Cerebral Cortex 10: 252-262. (Pubitemid 30159292)
    • (2000) Cerebral Cortex , vol.10 , Issue.3 , pp. 252-262
    • Roberts, A.C.1    Wallis, J.D.2
  • 59
    • 0036365967 scopus 로고    scopus 로고
    • Behavioral and Morphological Comparison of Two Nonhuman Primate Models of Huntington's Disease
    • Roitberg BZ, Emborg ME, Sramek JG, Palfi S, Kordower JH (2002) Behavioral and Morphological Comparison of Two Nonhuman Primate Models of Huntington's Disease. Neurosurgery 50: 137-146.
    • (2002) Neurosurgery , vol.50 , pp. 137-146
    • Roitberg, B.Z.1    Emborg, M.E.2    Sramek, J.G.3    Palfi, S.4    Kordower, J.H.5
  • 60
    • 33846238593 scopus 로고    scopus 로고
    • Impaired performance on the object retrieval-detour test of executive function in the SIV/macaque model of AIDS
    • DOI 10.1089/aid.2006.22.1031
    • Gray RA, Wilcox KM, Zink MC, Weed MR (2006) Impaired performance on the object retrieval-detour test of executive function in the SIV/macaque model of AIDS. AIDS Res Hum Retroviruses 22: 1031-1035. (Pubitemid 46100689)
    • (2006) AIDS Research and Human Retroviruses , vol.22 , Issue.10 , pp. 1031-1035
    • Gray, R.A.1    Wilcox, K.M.2    Zink, M.C.3    Weed, M.R.4
  • 61
    • 0025293227 scopus 로고
    • Cognitive and motor deficits in the acquisition of an object retrieval/detour task in MPTP-treated monkeys
    • Taylor JR, Elsworth JD, Roth RH, Sladek JR Jr, Redmond DE Jr (1990) Cognitive and motor deficits in the acquisition of an object retrieval/detour task in MPTP-treated monkeys. Brain 113 (Pt 3): 617-637. (Pubitemid 20222322)
    • (1990) Brain , vol.113 , Issue.3 , pp. 617-637
    • Taylor, J.R.1    Elsworth, J.D.2    Roth, R.H.3    Sladek Jr., J.R.4    Redmond Jr., D.E.5
  • 62
  • 63
    • 0030862672 scopus 로고    scopus 로고
    • Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine
    • DOI 10.1126/science.277.5328.953
    • Jentsch JD, Redmond DE, Elsworth JD, Taylor JR, Youngren KD, et al. (1997) Enduring Cognitive Deficits and Cortical Dopamine Dysfunction in Monkeys After Long-Term Administration of Phencyclidine. Science 277: 953-955. (Pubitemid 27366680)
    • (1997) Science , vol.277 , Issue.5328 , pp. 953-955
    • Jentsch, J.D.1    Redmond Jr., D.E.2    Elsworth, J.D.3    Taylor, J.R.4    Youngren, K.D.5    Roth, R.H.6
  • 64
    • 0032587235 scopus 로고    scopus 로고
    • 4 receptor antagonist reversal of subchronic phencyclidine- induced object retrieval/detour deficits in monkeys
    • DOI 10.1007/s002130050865
    • Jentsch JD, Taylor JR, Redmond DE Jr, Elsworth JD, Youngren KD, et al. (1999) Dopamine D4 receptor antagonist reversal of subchronic phencyclidine-induced object retrieval/detour deficits in monkeys. Psychopharmacology (Berl) 142: 78-84. (Pubitemid 29196067)
    • (1999) Psychopharmacology , vol.142 , Issue.1 , pp. 78-84
    • Jentsch, J.D.1    Taylor, J.R.2    Redmond Jr., D.E.3    Elsworth, J.D.4    Youngren, K.D.5    Roth, R.H.6
  • 66
  • 67
    • 0242460552 scopus 로고    scopus 로고
    • Dysregulation of protein kinase A signaling in the aged prefrontal cortex: New strategy for treating age-related cognitive decline
    • DOI 10.1016/S0896-6273(03)00694-9
    • Ramos BP, Birnbaum SG, Lindenmayer I, Newton SS, Duman RS, et al. (2003) Dysregulation of protein kinase a signaling in the aged prefrontal cortex: new strategy for treating age-related cognitive decline. Neuron 40: 835-845. (Pubitemid 37431042)
    • (2003) Neuron , vol.40 , Issue.4 , pp. 835-845
    • Ramos, B.P.1    Birnbaum, S.G.2    Lindenmayer, I.3    Newton, S.S.4    Duman, R.S.5    Arnsten, A.F.T.6
  • 68
    • 0035134037 scopus 로고    scopus 로고
    • A good practice guide to the administration of substances and removal of blood, including routes and volumes
    • Diehl KH, Hull R, Morton D, Pfister R, Rabemampianina Y, et al. (2001) A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Toxicol 21: 15-23.
    • (2001) J Appl Toxicol , vol.21 , pp. 15-23
    • Diehl, K.H.1    Hull, R.2    Morton, D.3    Pfister, R.4    Rabemampianina, Y.5
  • 69
    • 70350054854 scopus 로고    scopus 로고
    • Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids
    • Friden M, Winiwarter S, Jerndal G, Bengtsson O, Wan H, et al. (2009) Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids. J Med Chem 52: 6233-6243.
    • (2009) J Med Chem , vol.52 , pp. 6233-6243
    • Friden, M.1    Winiwarter, S.2    Jerndal, G.3    Bengtsson, O.4    Wan, H.5
  • 70
    • 78649706279 scopus 로고    scopus 로고
    • The effect of plasma protein binding on in vivo efficacy: Misconceptions in drug discovery
    • Smith DA, Di L, Kerns EH (2010) The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery. Nat Rev Drug Discov 9: 929-939.
    • (2010) Nat Rev Drug Discov , vol.9 , pp. 929-939
    • Smith, D.A.1    Di, L.2    Kerns, E.H.3
  • 71
    • 84872319925 scopus 로고    scopus 로고
    • Demystifying brain penetration in central nervous system drug discovery. Miniperspective
    • Di L, Rong H, Feng B (2013) Demystifying brain penetration in central nervous system drug discovery. Miniperspective. J Med Chem 56: 2-12.
    • (2013) J Med Chem , vol.56 , pp. 2-12
    • Di, L.1    Rong, H.2    Feng, B.3
  • 72
    • 0036790480 scopus 로고    scopus 로고
    • Deletion of phosphodiesterase 4D in mice shortens alpha2-adrenoceptor- mediated anesthesia, a behavioral correlate of emesis
    • Robichaud A (2002) Deletion of phosphodiesterase 4D in mice shortens alpha2-adrenoceptor-mediated anesthesia, a behavioral correlate of emesis. Journal of Clinical Investigation 110: 1045-1052.
    • (2002) Journal of Clinical Investigation , vol.110 , pp. 1045-1052
    • Robichaud, A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.